Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Why Mutual Funds & Institutional Investors Are Buying TBP

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Feb 06, 2022 9:12am

150 Views

Post# 34402124

RE:RE:RE:RE:RE:Why Mutual Funds & Institutional Investors Are Buying TBP

The presentation I shared was back in December I.e. less than 2 months ago. Listen to QIXLEEF part. It is pretty much what I stated. I don't know how frequent he is expected to show up but he might soon. He does usually after several weeks. Shsting again the video below.

https://youtu.be/eg6VpdrefyM